Clinical Trial Update: PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for PROSTVAC-VF/TRICOM vaccine in metastatic prostate cancer after failure of hormone therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• PROSTVAC-VF/TRICOM (PROSTVAC-VF/TRICOM)

Snippet

Sponsor: Bavarian Nordic | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED